Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Hitachi, Ltd.    6501   JP3788600009

News SummaryMost relevantAll newsSector newsTweets 

Hitachi, Ltd. : MOU to Start Exclusive Negotiations on Supply of Proton Beam Therapy System to Hospital No. 63 in Moscow, Russia

share with twitter share with LinkedIn share with facebook
share via e-mail
12/26/2013 | 04:02am CEST

Information contained in this news release is current as of the date of the press announcement, but may be subject to change without prior notice.

MOU to Start Exclusive Negotiations on Supply of Proton Beam
Therapy System to Hospital No. 63 in Moscow, Russia

Tokyo, December 26, 2013 --- Hitachi, Ltd. (TSE:6501) today announced that it has signed a memorandum of understanding (MOU) with Group of Companies European Medical Center (GEMC) in the Russian Federation,on the supply of a proton beam therapy system to hospital No. 63 in Moscow. Based on the MOU, Hitachi and GEMC will enter into exclusive negotiations with the aim of reaching a formal contract by the end of March 2014.

The irradiation of tumors with beams of accelerated particles (protons or carbon ions) has become recognized as a new form of cancer treatment. With a high incidence of cancer comparable to Japan or Europe, Russia is planning the construction of a number of new particle beam therapy facilities to strengthen its capabilities for treatment of the disease.

Backed by more than 20 years of history and tradition in Moscow, GEMC is one of the largest private medical service companies in Russia, operating 24-hour emergency clinics, pediatric hospitals, and women's hospitals at 5 locations in Moscow. The company is growing by creating private medical facilities, and providing them modern medical management and services in Moscow.

In April 2013, Hitachi entered into a strategic partnership with GEMC and the Budker Institute of Nuclear Physics (BINP) aimed at promoting the construction of hadron therapy systems in Russia. The new MOU announced today represents the first project to be initiated under this partnership. In addition to collaborating on construction through the supply of technical documents and other resources required for the building design, Hitachi will also be entering into exclusive negotiations toward a formal contract for supply of the system. It is expected that the contract will be signed by the end of March 2014.

Hitachi started developing proton beam therapy systems approximately 20 years ago. The technology has earned widespread recognition as an effective cancer treatment, with systems having been supplied to the University of Tsukuba and Nagoya Proton Therapy Center in Japan. Outside Japan, Hitachi has supplied a system to the MD Anderson Cancer Center in the USA, one of the world's largest specialist cancer hospitals. Particle beam therapy systems for Hokkaido University and three well-known clinics in the USA are currently under construction.

In addition to making an ongoing contribution to the wider adoption of advanced radiation therapy and other cancer treatments through the supply of particle beam therapy systems that incorporate leading-edge technologies such as spot scanning, Hitachi is also committed to the global operation of its healthcare and other social innovation businesses.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 326,000 employees worldwide. The company's consolidated revenues for fiscal 2012 (ended March 31, 2013) totaled 9,041 billion yen ($96.1 billion). Hitachi is focusing more than ever on the Social Innovation Business, which includes infrastructure systems, information & telecommunication systems, power systems, construction machinery, high functional material & components, automotive systems and others.http://www.hitachi.com.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on HITACHI, LTD.
04/21 HITACHI : Micro Clinic scripts a blockbuster fiscal
04/20 HITACHI KOKUSAI ELECTRIC : Researchers Submit Patent Application, "Method of Man..
04/20 HITACHI METALS : Patent Issued for Wiring Member (USPTO 9622393)
04/20 HITACHI : Patent Issued for Table Format Multi-Dimensional Data Translation Meth..
04/20 HITACHI : Patent Issued for Magnetic Resonance Imaging Apparatus and Irradiation..
04/20 HITACHI CONSTRUCTION MACHINERY : Patent Issued for Construction Machine (USPTO 9..
04/20 HITACHI : April 20, 2017New London Office for Co-creation of Digital Solutions i..
04/19 HITACHI : and Hirotsu Bio Science to Collaborate in Research for the Practical A..
04/18 INFRA PUSH MAY SPUR DEMAND FOR CONST : Tata Hitachi`s Sandeep Singh
04/18 HITACHI : April 18, 2017Hitachi and Hirotsu Bio Science to Collaborate in Resear..
More news
Sector news : Industrial Conglomerates
04/22DJGENERAL ELECTRIC : Industrial Unit Buoys GE -- WSJ
04/21 Honeywell profit beats; shares hit record high
04/21DJGENERAL ELECTRIC : GE, Still Weighed by Energy, Boosts Profit Amid Cost Cutting ..
04/21 GENERAL ELECTRIC : CEO says 'we see global growth accelerating'
04/21 Honeywell profit beats as aerospace, energy businesses deliver
More sector news : Industrial Conglomerates
News from SeekingAlpha
04/09 Analysts Say These Large Cap Stocks Are Seriously Undervalued
02/14 Wave Power - Is It Going To Work?
02/07 WALL STREET BREAKFAST : Earnings Season Kicks Into High Gear
02/07 Honda, Hitachi form EV motor joint venture
02/01 Hitachi's (HTHIY) Management on Q3 2017 Results - Earnings Call Transcript
Financials ( JPY)
Sales 2017 9 020 293 M
EBIT 2017 542 500 M
Net income 2017 227 308 M
Debt 2017 1 675 839 M
Yield 2017 2,11%
P/E ratio 2017 12,62
P/E ratio 2018 10,54
EV / Sales 2017 0,50x
EV / Sales 2018 0,49x
Capitalization 2 839 176 M
More Financials
Duration : Period :
Hitachi, Ltd. Technical Analysis Chart | 6501 | JP3788600009 | 4-Traders
Full-screen chart
Technical analysis trends HITACHI, LTD.
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 742  JPY
Spread / Average Target 26%
Consensus details
EPS Revisions
More Estimates Revisions
Toshiaki Higashihara Executive President, CEO & Director
Hiroaki Nakanishi Chairman
Mitsuaki Nishiyama Chief Financial Officer
Shinichiro Omori Chief Information & Transformation Officer
Norihiro Suzuki Chief Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HITACHI, LTD.-7.01%26 015
3M CO7.24%114 440
SIEMENS AG7.32%114 268
E I DU PONT DE NEMOURS..7.15%67 999
More Results